BEIJING, Dec. 8, 2022
/PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the
"Company"), a leading provider of tech-powered, intellectual
development products in China,
today announced its unaudited financial results for the
third quarter ended September 30, 2022.
Third Quarter 2022 Highlights
- Revenues were RMB251.5 million
(US$35.4 million), compared with
RMB259.0 million in the same period
last year.
- Gross profit was RMB177.1 million
(US$24.9 million), compared with
RMB180.2 million in the same period
last year.
- Operating income reached a record-high of RMB38.5 million (US$5.4
million), a remarkable turnaround compared with an operating
loss of RMB43.9 million in the same
period last year.
- Adjusted operating income[1] reached a record-high
of RMB42.5 million (US$6.0 million), a remarkable turnaround compared
with an adjusted operating loss of RMB41.5
million in the same period last year.
- Net income reached a record-high of RMB39.5 million (US$5.5
million), a remarkable turnaround compared with a net loss
of RMB38.2 million in the same period
last year.
- Adjusted net income[1] reached a record-high of
RMB43.5 million (US$6.1 million), a remarkable turnaround compared
with an adjusted net loss of RMB35.8
million in the same period last year.
- Average total MAUs[2] reached a record-high of 20.63
million, a year-over-year increase of 16.7%.
Dr. Peng Dai, Director and Chief
Executive Officer of iHuman, commented, "Building on our momentum
in the first half of the year, we are pleased to deliver another
set of solid results in the third quarter. Our average total MAUs
hit an all-time high, increasing by 17% year-over-year to 20.63 million. The strong growth and
continued expansion of our user base not only reflects the growing
engagement and activeness of our user community, but also further
validates the effectiveness of our focused organic user acquisition
strategy. In the quarter, we optimized our domestic product
portfolio to continue enhancing user experience and achieved some
encouraging progress in our international business. Recently, we
launched bekids Puzzle and bekids ABC, two more key
milestones on our international roadmap. bekids Puzzle is
designed to improve thinking skills in fun and meaningful ways, and
provides more visual appeal, entertainment, and challenge than
traditional puzzles. bekids ABC is an all-in-one app
designed to provide essential early-years enlightenment for
children, improving their reading, logic, and social skills.
Meanwhile, we are stepping up our efforts to develop new products
aligned with international market demand, and expect to gradually
roll out these new offerings in the near future. Although our
expansion efforts are still in an early stage, we are delighted to
see that the business is gaining traction and market recognition.
For example, bekids Coloring, an app designed to inspire
children's artistic creativity and develop their visual literacy
via fun and interactive drawing activities, has already received
two prestigious awards from the "Mom's Choice Awards" (MCA) and
"Parent Tested Parent Approved" (PTPA), two of North America's best-recognized and most
influential family product awards organizations. We believe
distinguished acknowledgments like these represent a strong
testament to the excellence of bekids Coloring, and will
help drive product adoption among international families, and boost
market awareness of our Bekids brand as a whole. Our
expanded user base in the domestic market, ever-strengthening
product pipeline, and growing recognition in the international
market further give us confidence in our ability to unlock
long-term opportunities and business growth. Going forward, we
remain committed to our product-driven growth strategies and will
continue to invest in key strategic priorities."
Ms. Vivien Weiwei Wang, Director
and Chief Financial Officer of iHuman, added, "In the third
quarter, we continued to make progress in improving profitability
at scale while continuing to drive quality growth. We reached a
record-high quarterly adjusted net income of RMB43.5 million, and achieved a third
consecutive quarter of profitability. The continued improvement in
profitability was primarily driven by our sound operating
efficiency initiatives. We better aligned our cost structure with
our strategic priorities and improved our operational efficiency by
further streamlining key business processes and workflows. For
example, by leveraging our strong big data and AI capabilities to
personalize product recommendations, we effectively directed user
traffic of our flagship products to our newer offerings, elevating
our cross-sell opportunities and enhancing user acquisition
efficiency. Looking ahead, we will work diligently to innovate new
products and remain focused on operational excellence to drive
healthy and sustainable business growth."
Third Quarter 2022 Unaudited Financial Results
Revenues
Revenues were RMB251.5 million
(US$35.4 million), a slight decrease
of 2.9% from RMB259.0 million in the
same period last year.
Average total MAUs for the quarter were 20.63 million, an
increase of 16.7% year-over-year from 17.68 million in the same
period last year. The number of paying users[3] for the
quarter was 1.65 million.
Cost of Revenues
Cost of revenues was RMB74.4
million (US$10.5 million), a
decrease of 5.5% from RMB78.8 million
in the same period last year.
Gross Profit and Gross Margin
Gross profit was RMB177.1 million
(US$24.9 million), a slight decrease
of 1.7% from RMB180.2 million in the
same period last year. Gross margin was 70.4%, compared with 69.6%
in the same period last year.
Operating Expenses
Total operating expenses were RMB138.6
million (US$19.5 million), a
decrease of 38.2% from RMB224.1
million in the same period last year.
Research and development expenses were RMB71.9 million (US$10.1
million), a decrease of 45.2% from RMB131.1 million in the same period last year,
primarily due to cost savings in payroll-related expenses and
outsourcing expenses.
Sales and marketing expenses were RMB41.7 million (US$5.9 million), a decrease of 38.0% from
RMB67.2 million in the same period
last year, primarily due to an economical and optimized advertising
strategy.
General and administrative expenses were RMB25.0 million (US$3.5 million), a decrease of 2.8% from
RMB25.8 million in the same period
last year.
Operating Income
Operating income was RMB38.5
million (US$5.4 million),
compared with an operating loss of RMB43.9
million in the same period last year.
Excluding share-based compensation expenses, adjusted operating
income was RMB42.5 million
(US$6.0 million), compared with an
adjusted operating loss of RMB41.5
million in the same period last year.
Net Income
Net income was RMB39.5 million
(US$5.5 million), compared with a net
loss of RMB38.2 million in the same
period last year.
Adjusted net income was RMB43.5
million (US$6.1 million),
compared with an adjusted net loss of RMB35.8 million in the same period last year.
Basic and diluted net income per ADS were RMB0.74 (US$0.10)
and RMB0.73 (US$0.10), respectively, compared with basic and
diluted net loss per ADS of RMB0.72
in the same period last year. Each ADS represents five Class A
ordinary shares of the Company.
Adjusted diluted net income per ADS was RMB0.80 (US$0.11),
compared with adjusted diluted net loss per ADS of RMB0.67 in the same period last year.
Deferred Revenue and Customer
Advances
Deferred revenue and customer advances were RMB340.7 million (US$47.9
million) as of September 30,
2022, compared with RMB303.0
million as of December 31,
2021.
Cash, Cash Equivalents and Time Deposits
Cash, cash equivalents and time deposits were RMB949.6 million (US$133.5
million) as of September 30,
2022, compared with RMB855.4
million as of December 31,
2021.
[1] "Adjusted operating
income" and "adjusted net income" exclude share-based compensation
expenses. Please see "Non-GAAP Financial Measures" and "Unaudited
Reconciliation of GAAP and non-GAAP Results" at the end of this
press release.
|
[2] "Average total
MAUs" refers to the monthly average of the sum of the MAUs of each
of the Company's apps during a specific period, which is counted
based on the number of unique mobile devices through which such app
is accessed at least once in a given month, and duplicate access to
different apps is not eliminated from the total MAUs
calculation.
|
[3] "Paying users"
refers to users who paid subscription fees for premium content on
any of the Company's apps during a specific period; a user who
makes payments across different apps using the same registered
account is counted as one paying user, and a user who makes
payments for the same app multiple times in the same period is
counted as one paying user.
|
|
Modification of Exercise Prices of Share Options
In September 2022, to provide
additional incentives to the Company's employees, the Company
modified the exercise prices for eligible outstanding options as of
September 30, 2022, originally
granted with exercise prices above US$0.2 per Class A ordinary share to the
employees. Upon the modification, the exercise prices of these
options were decreased to US$0.2 per
Class A ordinary share, while other terms remained unchanged.
Extension of Share Repurchase Program
As announced on December 21, 2021,
the Company's board of directors (the "Board") has authorized a
share repurchase plan under which the Company may repurchase up to
US$10 million of its shares over the
next 12 months. Given its confidence in the Company's business
prospects, the Board has authorized an extension of the share
repurchase program for another 12 months until December 31, 2023. Pursuant to the extended share
repurchase program, the Company's proposed repurchases may be made
from time to time through open market transactions at prevailing
market prices, in privately negotiated transactions, in block
trades and/or through other legally permissible means, depending on
the market conditions and in accordance with applicable rules and
regulations. The timing and dollar amount of repurchase
transactions will be subject to the Securities and Exchange
Commission (the "SEC") Rule 10b-18
and/or Rule 10b5-1 requirements. The Board will continue to review
the extended share repurchase program periodically, and may
authorize adjustments to its terms and size. The Company expects to
continue to fund the repurchases under the extended share
repurchase program with its existing cash balance.
Exchange Rate Information
The U.S. dollar (US$) amounts disclosed in this press release,
except for those transaction amounts that were actually settled in
U.S. dollars, are presented solely for the convenience of the
reader. The conversion of Renminbi (RMB) into US$ in this press
release is based on the exchange rate set forth in the H.10
statistical release of the Board of Governors of the Federal
Reserve System as of September 30,
2022, which was RMB7.1135 to
US$1.00. The percentages stated in
this press release are calculated based on the RMB amounts.
Non-GAAP Financial Measures
iHuman considers and uses non-GAAP financial measures, such as
adjusted operating income, adjusted net income and adjusted diluted
net income per ADS, as supplemental metrics in reviewing and
assessing its operating performance and formulating its business
plan. The presentation of non-GAAP financial measures is not
intended to be considered in isolation or as a substitute for the
financial information prepared and presented in accordance with
accounting principles generally accepted in the United States of America ("U.S. GAAP").
iHuman defines adjusted operating income, adjusted net income and
adjusted diluted net income per ADS as operating income, net income
and diluted net income per ADS excluding share-based compensation
expenses, respectively. Adjusted operating income, adjusted net
income and adjusted diluted net income per ADS enable iHuman's
management to assess its operating results without considering the
impact of share-based compensation expenses, which are non-cash
charges. iHuman believes that these non-GAAP financial measures
provide useful information to investors in understanding and
evaluating the Company's current operating performance and
prospects in the same manner as management does, if they so
choose.
Non-GAAP financial measures are not defined under U.S. GAAP and
are not presented in accordance with U.S. GAAP. Non-GAAP financial
measures have limitations as analytical tools, which possibly do
not reflect all items of expense that affect our operations.
Share-based compensation expenses have been and may continue to be
incurred in our business and are not reflected in the presentation
of the non-GAAP financial measures. In addition, the non-GAAP
financial measures iHuman uses may differ from the non-GAAP
measures used by other companies, including peer companies, and
therefore their comparability may be limited. The presentation of
these non-GAAP financial measures is not intended to be considered
in isolation from or as a substitute for the financial information
prepared and presented in accordance with GAAP.
Safe Harbor Statement
This announcement contains forward-looking statements. These
statements are made under the "safe harbor" provisions of the
United States Private Securities Litigation Reform Act of 1995.
These forward-looking statements can be identified by terminology
such as "will," "expects," "anticipates," "future," "intends,"
"plans," "believes," "estimates" and similar statements.
Statements that are not historical facts, including statements
about iHuman's beliefs and expectations, are forward-looking
statements. Among other things, the description of the management's
quotations in this announcement contains forward-looking
statements. iHuman may also make written or oral forward-looking
statements in its periodic reports to the U.S. Securities and
Exchange Commission (the "SEC"), in its annual report to
shareholders, in press releases and other written materials, and in
oral statements made by its officers, directors or employees to
third parties. Forward-looking statements involve inherent risks
and uncertainties. A number of factors could cause actual results
to differ materially from those contained in any forward-looking
statement, including but not limited to the following: iHuman's
growth strategies; its future business development, financial
condition and results of operations; its ability to continue to
attract and retain users, convert non-paying users into paying
users and increase the spending of paying users, the trends in, and
size of, the market in which iHuman operates; its expectations
regarding demand for, and market acceptance of, its products and
services; its expectations regarding its relationships with
business partners; general economic and business conditions;
regulatory environment; and assumptions underlying or related to
any of the foregoing. Further information regarding these and other
risks is included in iHuman's filings with the SEC. All information
provided in this press release is as of the date of this press
release, and iHuman does not undertake any obligation to update any
forward-looking statement, except as required under applicable
law.
About iHuman Inc.
iHuman Inc. is a leading provider of tech-powered, intellectual
development products in China that
is committed to making the child-rearing experience easier for
parents and transforming cognitive development into a fun journey
for children. Benefiting from a deep legacy that combines over two
decades of experience in the parenthood industry, superior original
content, advanced high-tech innovation DNA and research &
development capabilities with cutting-edge technologies, iHuman
empowers parents with tools to make the child-upbringing experience
more efficient. iHuman's unique, fun and interactive product
offerings stimulate children's natural curiosity and exploration.
The Company's comprehensive suite of innovative and high-quality
products include self-directed apps, interactive content and smart
devices that cover a broad variety of areas to develop children's
abilities in speaking, critical thinking, independent reading and
creativity, and foster their natural interest in traditional
Chinese culture. Leveraging advanced technological capabilities,
including 3D engines, AI/AR functionality, and big data analysis on
children's behavior & psychology, iHuman believes it will
continue to provide superior experience that is efficient and
relieving for parents, and effective and fun for children, in
China and all over the world,
through its integrated suite of tech-powered, intellectual
development products.
For more information about iHuman, please visit
https://ir.ihuman.com/.
For investor and media enquiries, please contact:
iHuman Inc.
Mr. Justin Zhang
Investor Relations Director
Phone: +86 10 5780-6606
E-mail: ir@ihuman.com
Christensen
In China
Mr. Eric Yuan
Phone: +86-13801110739
E-mail: eric.yuan@christensencomms.com
In the US
Ms. Linda Bergkamp
Phone: +1-480-614-3004
E-mail: linda.bergkamp@christensencomms.com
iHuman Inc.
UNAUDITED CONDENSED
CONSOLIDATED BALANCE SHEETS
(Amounts in
thousands of Renminbi ("RMB") and U.S. dollars
("US$")
except for number of
shares, ADSs, per share and per ADS
data)
|
|
|
|
|
|
|
|
December
31,
|
|
September
30,
|
|
September
30,
|
|
2021
|
|
2022
|
|
2022
|
|
RMB
|
|
RMB
|
|
US$
|
|
|
|
|
|
|
ASSETS
|
|
|
|
|
|
Current
assets
|
|
|
|
|
|
Cash and cash
equivalents
|
855,362
|
|
878,606
|
|
123,512
|
Time
deposits
|
-
|
|
70,998
|
|
9,981
|
Accounts receivable,
net
|
56,132
|
|
76,215
|
|
10,714
|
Inventories,
net
|
28,054
|
|
16,520
|
|
2,322
|
Amounts due from
related parties
|
2,845
|
|
4,193
|
|
589
|
Prepayments and other
current assets
|
72,851
|
|
93,726
|
|
13,176
|
Total current
assets
|
1,015,244
|
|
1,140,258
|
|
160,294
|
Non-current
assets
|
|
|
|
|
|
Property and
equipment, net
|
12,286
|
|
9,801
|
|
1,378
|
Intangible assets,
net
|
27,287
|
|
26,878
|
|
3,778
|
Operating
lease right-of-use assets
|
38,237
|
|
17,311
|
|
2,434
|
Long-term
investment
|
-
|
|
26,333
|
|
3,702
|
Amounts due from
related parties
|
4,223
|
|
-
|
|
-
|
Other non-current
assets
|
3,604
|
|
4,108
|
|
578
|
Total non-current
assets
|
85,637
|
|
84,431
|
|
11,870
|
Total
assets
|
1,100,881
|
|
1,224,689
|
|
172,164
|
|
|
|
|
|
|
LIABILITIES
|
|
|
|
|
|
Current
liabilities
|
|
|
|
|
|
Accounts
payable
|
30,536
|
|
13,912
|
|
1,956
|
Deferred revenue and
customer advances
|
302,980
|
|
340,737
|
|
47,900
|
Amounts due to related
parties
|
8,853
|
|
8,922
|
|
1,254
|
Accrued expenses and
other current liabilities
|
115,895
|
|
108,037
|
|
15,188
|
Current operating
lease liabilities
|
24,669
|
|
10,490
|
|
1,475
|
Total current
liabilities
|
482,933
|
|
482,098
|
|
67,773
|
Non-current
liabilities
|
|
|
|
|
|
Non-current operating
lease liabilities
|
9,577
|
|
3,197
|
|
449
|
Total non-current
liabilities
|
9,577
|
|
3,197
|
|
449
|
Total
liabilities
|
492,510
|
|
485,295
|
|
68,222
|
SHAREHOLDERS'
EQUITY
|
|
|
|
|
|
Ordinary shares (par
value of US$0.0001 per share,
700,000,000 Class A shares authorized as of December
31, 2021 and September 30, 2022; 125,122,382 Class A
shares issued and 123,852,667 outstanding as of
December 31, 2021; 125,122,382 Class A shares issued
and 122,150,597 outstanding as of September 30, 2022;
200,000,000 Class B shares authorized, 144,000,000
Class B ordinary shares issued and outstanding as of
December 31, 2021 and September 30, 2022; 100,000,000
shares (undesignated) authorized, nil shares
(undesignated) issued and outstanding as of December
31,
2021 and
September 30, 2022)
|
185
|
|
185
|
|
26
|
Additional paid-in
capital
|
1,066,052
|
|
1,074,051
|
|
150,988
|
Treasury
stock
|
(164)
|
|
(5,711)
|
|
(803)
|
Accumulated other
comprehensive income (loss)
|
(34,677)
|
|
19,508
|
|
2,742
|
Accumulated
deficit
|
(423,025)
|
|
(348,639)
|
|
(49,011)
|
Total shareholders'
equity
|
608,371
|
|
739,394
|
|
103,942
|
Total liabilities
and shareholders' equity
|
1,100,881
|
|
1,224,689
|
|
172,164
|
iHuman Inc.
UNAUDITED
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Amounts in
thousands of Renminbi ("RMB") and U.S. dollars
("US$")
except for number
of shares, ADSs, per share and per ADS data)
|
|
|
|
|
|
For the three months
ended
|
|
For the nine months
ended
|
|
September
30,
|
|
June
30,
|
|
September
30,
|
|
September
30,
|
|
September
30,
|
|
September
30,
|
|
September
30,
|
|
2021
|
|
2022
|
|
2022
|
|
2022
|
|
2021
|
|
2022
|
|
2022
|
|
RMB
|
|
RMB
|
|
RMB
|
|
US$
|
|
RMB
|
|
RMB
|
|
US$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
258,983
|
|
230,607
|
|
251,527
|
|
35,359
|
|
706,900
|
|
724,813
|
|
101,893
|
Cost of
revenues
|
(78,785)
|
|
(67,417)
|
|
(74,422)
|
|
(10,462)
|
|
(211,185)
|
|
(214,636)
|
|
(30,173)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross
profit
|
180,198
|
|
163,190
|
|
177,105
|
|
24,897
|
|
495,715
|
|
510,177
|
|
71,720
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and
development expenses
|
(131,088)
|
|
(78,201)
|
|
(71,859)
|
|
(10,102)
|
|
(306,253)
|
|
(246,685)
|
|
(34,678)
|
Sales and marketing
expenses
|
(67,216)
|
|
(33,530)
|
|
(41,669)
|
|
(5,858)
|
|
(165,441)
|
|
(111,105)
|
|
(15,619)
|
General and
administrative expenses
|
(25,761)
|
|
(28,849)
|
|
(25,035)
|
|
(3,519)
|
|
(67,694)
|
|
(79,942)
|
|
(11,238)
|
Total operating
expenses
|
(224,065)
|
|
(140,580)
|
|
(138,563)
|
|
(19,479)
|
|
(539,388)
|
|
(437,732)
|
|
(61,535)
|
Operating income
(loss)
|
(43,867)
|
|
22,610
|
|
38,542
|
|
5,418
|
|
(43,673)
|
|
72,445
|
|
10,185
|
Other income,
net
|
5,695
|
|
2,917
|
|
9,611
|
|
1,351
|
|
14,361
|
|
15,875
|
|
2,232
|
Income (loss) before
income taxes
|
(38,172)
|
|
25,527
|
|
48,153
|
|
6,769
|
|
(29,312)
|
|
88,320
|
|
12,417
|
Income tax benefit
(expenses)
|
(23)
|
|
(3,737)
|
|
(8,675)
|
|
(1,220)
|
|
170
|
|
(13,934)
|
|
(1,959)
|
Net income
(loss)
|
(38,195)
|
|
21,790
|
|
39,478
|
|
5,549
|
|
(29,142)
|
|
74,386
|
|
10,458
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
per ADS:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-
Basic
|
(0.72)
|
|
0.41
|
|
0.74
|
|
0.10
|
|
(0.55)
|
|
1.39
|
|
0.20
|
-
Diluted
|
(0.72)
|
|
0.40
|
|
0.73
|
|
0.10
|
|
(0.55)
|
|
1.38
|
|
0.19
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average
number of ADSs:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-
Basic
|
53,324,476
|
|
53,308,924
|
|
53,240,710
|
|
53,240,710
|
|
53,324,476
|
|
53,341,120
|
|
53,341,120
|
-
Diluted
|
53,324,476
|
|
53,958,284
|
|
54,114,651
|
|
54,114,651
|
|
53,324,476
|
|
54,043,728
|
|
54,043,728
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total share-based
compensation expenses included in:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of
revenues
|
244
|
|
39
|
|
77
|
|
11
|
|
768
|
|
180
|
|
25
|
Research and
development expenses
|
(24)
|
|
801
|
|
2,045
|
|
287
|
|
5,211
|
|
3,813
|
|
536
|
Sales and marketing
expenses
|
767
|
|
430
|
|
698
|
|
98
|
|
2,930
|
|
1,040
|
|
146
|
General and
administrative expenses
|
1,379
|
|
762
|
|
1,187
|
|
167
|
|
4,740
|
|
2,963
|
|
417
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
iHuman Inc.
UNAUDITED
RECONCILIATION OF GAAP AND NON-GAAP RESULTS
(Amounts in
thousands of Renminbi ("RMB") and U.S. dollars
("US$")
except for number
of shares, ADSs, per share and per ADS data)
|
|
|
|
|
|
For the three months
ended
|
|
For the nine months
ended
|
|
September
30,
|
|
June
30,
|
|
September
30,
|
|
September
30,
|
|
September
30,
|
|
September
30,
|
|
September
30,
|
|
2021
|
|
2022
|
|
2022
|
|
2022
|
|
2021
|
|
2022
|
|
2022
|
|
RMB
|
|
RMB
|
|
RMB
|
|
US$
|
|
RMB
|
|
RMB
|
|
US$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
(loss)
|
(43,867)
|
|
22,610
|
|
38,542
|
|
5,418
|
|
(43,673)
|
|
72,445
|
|
10,185
|
Share-based
compensation expenses
|
2,366
|
|
2,032
|
|
4,007
|
|
563
|
|
13,649
|
|
7,996
|
|
1,124
|
Adjusted operating
income (loss)
|
(41,501)
|
|
24,642
|
|
42,549
|
|
5,981
|
|
(30,024)
|
|
80,441
|
|
11,309
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
(loss)
|
(38,195)
|
|
21,790
|
|
39,478
|
|
5,549
|
|
(29,142)
|
|
74,386
|
|
10,458
|
Share-based
compensation expenses
|
2,366
|
|
2,032
|
|
4,007
|
|
563
|
|
13,649
|
|
7,996
|
|
1,124
|
Adjusted net income
(loss)
|
(35,829)
|
|
23,822
|
|
43,485
|
|
6,112
|
|
(15,493)
|
|
82,382
|
|
11,582
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted net income
(loss) per ADS
|
(0.72)
|
|
0.40
|
|
0.73
|
|
0.10
|
|
(0.55)
|
|
1.38
|
|
0.19
|
Impact of non-GAAP
adjustments
|
0.05
|
|
0.04
|
|
0.07
|
|
0.01
|
|
0.26
|
|
0.14
|
|
0.02
|
Adjusted diluted net
income (loss) per ADS
|
(0.67)
|
|
0.44
|
|
0.80
|
|
0.11
|
|
(0.29)
|
|
1.52
|
|
0.21
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number
of ADSs – diluted
|
53,324,476
|
|
53,958,284
|
|
54,114,651
|
|
54,114,651
|
|
53,324,476
|
|
54,043,728
|
|
54,043,728
|
Weighted average
number of ADSs – adjusted
|
53,324,476
|
|
53,958,284
|
|
54,114,651
|
|
54,114,651
|
|
53,324,476
|
|
54,043,728
|
|
54,043,728
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ihuman-inc-announces-third-quarter-2022-unaudited-financial-results-301697881.html
SOURCE iHuman Inc.